BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24029073)

  • 1. Understanding the role of NRF2-regulated miRNAs in human malignancies.
    Shah NM; Rushworth SA; Murray MY; Bowles KM; MacEwan DJ
    Oncotarget; 2013 Aug; 4(8):1130-42. PubMed ID: 24029073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure.
    Tian C; Gao L; Zimmerman MC; Zucker IH
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H928-H939. PubMed ID: 29373037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as regulators of VEGFA and NFE2L2 in cancer.
    Cuzziol CI; Castanhole-Nunes MMU; Pavarino ÉC; Goloni-Bertollo EM
    Gene; 2020 Oct; 759():144994. PubMed ID: 32721475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
    Cheng X; Ku CH; Siow RC
    Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
    Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
    Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between NRF2 and Dicer through metastasis regulating MicroRNAs; mir-34a, mir-200 family and mir-103/107 family.
    Nabih HK
    Arch Biochem Biophys; 2020 Jun; 686():108326. PubMed ID: 32142889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepiapterin alleviates impaired gastric nNOS function in spontaneous diabetic female rodents through NRF2 mRNA turnover and miRNA biogenesis pathway.
    Gangula PR; Challagundla KB; Ravella K; Mukhopadhyay S; Chinnathambi V; Mittal MK; Sekhar KR; Sampath C
    Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G980-G990. PubMed ID: 30285465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs.
    Paladino S; Conte A; Caggiano R; Pierantoni GM; Faraonio R
    Cell Physiol Biochem; 2018; 47(5):1951-1976. PubMed ID: 29969760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease.
    Kaundal RK; Datusalia AK; Sharma SS
    Pharmacol Res; 2022 Jan; 175():106018. PubMed ID: 34863823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
    Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
    Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.
    Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J
    Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
    Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dual Roles of NRF2 in Cancer.
    Menegon S; Columbano A; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs mediate the senescence-associated decline of NRF2 in endothelial cells.
    Kuosmanen SM; Sihvola V; Kansanen E; Kaikkonen MU; Levonen AL
    Redox Biol; 2018 Sep; 18():77-83. PubMed ID: 29986211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs.
    Tian C; Gao L; Zucker IH
    Free Radic Biol Med; 2021 May; 167():218-231. PubMed ID: 33741451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRF2 and microRNAs: new but awaited relations.
    Kurinna S; Werner S
    Biochem Soc Trans; 2015 Aug; 43(4):595-601. PubMed ID: 26551699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.
    Smolková K; Mikó E; Kovács T; Leguina-Ruzzi A; Sipos A; Bai P
    Antioxid Redox Signal; 2020 Nov; 33(13):966-997. PubMed ID: 31989830
    [No Abstract]   [Full Text] [Related]  

  • 18. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.
    Yang M; Yao Y; Eades G; Zhang Y; Zhou Q
    Breast Cancer Res Treat; 2011 Oct; 129(3):983-91. PubMed ID: 21638050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2: bane or blessing in cancer?
    Xiang M; Namani A; Wu S; Wang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1251-9. PubMed ID: 24599821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.
    Teimouri M; Hosseini H; Shabani M; Koushki M; Noorbakhsh F; Meshkani R
    IUBMB Life; 2020 Mar; 72(3):361-372. PubMed ID: 31889412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.